Here's Why Seattle Genetics Climbed 17.6% in September

Shares of Seattle Genetics (NASDAQ: SGEN) jumped 17.6% in September, according to data provided by S&P Global Market Intelligence, as the biotech rounded out the month with positive data from a pair of clinical trials presented at the 2019 European Society for Medical Oncology (ESMO) Congress.